Strados Labs, a Philadelphia-based medical technology company, has been authorized by the Food and Drug Administration to use its RESP respiratory monitoring system at home. The 6-year-old company called the FDA authorization, the second in less than 18 months, a “major step” because it will allow the product to be used by patients in their homes for remote monitoring of associated symptoms. lung disease. It can also be used in teleheath connections between patients and their doctors.

By philcp

Leave a Reply

Your email address will not be published.